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INTRODUCTION 
Liver fibrosis is a common response to chronic liver injury and is 
known to arise from a variety of viral, alcohol and drug-induced 
causes. As significant fibrosis may progress to cirrhosis with or 
without hepatocellular carcinoma, antiviral treatment is recom-
mended for patients with significant fibrosis. Accordingly, liver fi-
brosis grading is essential for proper management of patient as 
mild fibrosis needs to be monitored and those with significant fi-
brosis must be treated.1-3 Although liver biopsy has remained as a 
gold standard for diagnosing liver fibrosis and cirrhosis, It is an in-
vasive procedure and poses a risk of severe complications. In ad-
dition, biopsy results are subject to sampling error related to the 
heterogeneity of the distribution of liver fibrosis.4,5 On the other 
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Background/Aims: To assess the usefulness of magnetization-tagged magnetic resonance imaging (MRI) in quantifying 
cardiac-induced liver motion and deformation in order to predict liver fibrosis. 
Methods: This retrospective study included 85 patients who underwent liver MRI including magnetization-tagged 
sequences from April 2010 to August 2010. Tagged images were acquired in three coronal and three sagittal planes 
encompassing both the liver and heart. A Gabor filter bank was used to measure the maximum value of displacement 
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aminotransferase-to-platelet ratio index (APRI) score. Group comparisons were made using ANOVA tests.
Results: The patients were divided into three groups according to APRI scores: no fibrosis (≤0.5; n=41), moderate fibrosis 
(0.5–1.5; n=23), and significant fibrosis (>1.5; n=21). The values of MaxDisp were 2.9±0.9 (mean±SD), 2.3±0.7, and 2.1±0.6 
in the no fibrosis, moderate fibrosis, and significant fibrosis groups, respectively (P<0.001); the corresponding values 
of MaxP1 were 0.05±0.2, 0.04±0.02, and 0.03±0.01, respectively (P=0.002), while those of MinP2 were –0.07±0.02, 
–0.05±0.02, and –0.04±0.01, respectively (P<0.001). 
Conclusions: Tagged MRI to quantify cardiac-induced liver motion can be easily incorporated in routine liver MRI and 
may represent a helpful complementary tool in the diagnosis of early liver fibrosis. (Clin Mol Hepatol 2016;22:140-145)
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hand, non-invasive methods are being investigated for the diag-
nosis of liver fibrosis including ultrasound-based transient elas-
tography and magnetic resonance imaging (MRI)-based studies 
using MR elastography.6-9 Ultrasound-based transient elastogra-
phy is simple, but involves measurement limitations in regards to 
depth and in patients with obesity.10 Although MR elastography is 
known to be accurate, it requires special-purpose hardware in or-
der to generate an externally induced vibration wave.11 Alterna-
tively, recent studies on magnetization-tagged MRI have shown 
that cardiac-induced liver motion can be measured to noninva-
sively assess liver stiffness.12 Therewith, pulsations of the heart as 
an intrinsic motion source are transmitted to the adjacent portion 
of the liver during the cardiac cycle, resulting in relatively localized 
motion and deformation of the liver. This motion of the liver can 
be imaged using tagged MRI.
Among the serologic markers for liver fibrosis, AST to platelet 
ratio index (APRI) is a simple index that can be calculated using 
readily available laboratory results, and is reported to demon-
strate a high degree of accuracy in the diagnosis of significant liv-
er fibrosis.13-17
The purpose of this study was to assess the usefulness of 
tagged MRI of cardiac-induced liver motion in staging liver fibrosis 
compared to the simple serologic marker APRI, and to test for its 
potential use as a routine MRI sequence. 
MATERIAL AND METHODS
The institutional review board of our institution approved this 
retrospective study, and informed consent was waived. We retro-
spectively reviewed magnetization-tagged MRI of the patients 
who were prospectively enrolled for another research (IRB #4-
2010-0303), where it was addressed whether magnetization-
tagged MRI is correlated with Child-Pugh scores.18
Subjects 
From April 2010 to August 2010, 175 patients underwent liver 
MRI with magnetization-tagged sequence at our institution for 
various diagnostic purposes. Ninety patients were excluded from 
this study due to a history of underlying heart disease (n=6); a 
history of treatment for liver disease, such as hepatic resection, 
transarterial chemo-embolization or radio-frequency ablation 
(n=30); a history of systemic chemotherapy (n=28); the presence 
of space occupying lesions in the left hepatic lobe larger than 2 
cm (n=17); and suboptimal quality MR images for which to ana-
lyze liver fibrosis because of respiratory motion artifacts, atrophic 
change in the left hepatic lobe, or a large amount of ascites (n=9). 
The failure rate of this sequence is about 5.1% (9/175). Conse-
quently, a total of 85 patients with tagged MRI were included in 
this study. Of the 85 patients (57.6±10.0 years old, 57 males and 
28 females), 62 (72.9%) patients had chronic liver disease [hepa-
titis B (n=47), hepatitis C (n=12), alcoholic liver disease (n=6)] 
and 23 patients had small (<2 cm) focal liver lesions without pa-
renchymal abnormality [liver metastasis (n=13) and other benign 
focal liver lesions (n=10)].
Clinical analysis
Medical records of the patients were retrospectively reviewed 
for clinical information. All patients underwent routine complete 
blood count (CBC) tests with platelet count and serum biochemi-
cal tests including aspartate aminotransferase (AST) within 1 
week of undergoing tagged MRI. AST to platelet ratio index 
(APRI) was calculated using the following formula.13,14 APRI = AST 
level (/upper limit of normal)/platelet counts (109/L)×100. An APRI 
score below the lower cut-off value (0.50) was defined as no fi-
brosis, while an APRI score above the higher cut-off value (1.50) 
was defined as significant fibrosis.13 An APRI score between the 
lower and higher cut-off values was defined as moderate fibrosis.
MRI protocol 
Subjects were scanned using 3T MRI systems (Tim Trio, Siemens 
Medical Solutions, Erlangen, Germany) with standard phase-array 
coils. An electrocardiogram-gated tagged MR sequence was per-
formed while the subjects held their breath and using the follow-
ing imaging parameters12 : echo time=3.9 msec, pulse repetition 
time=8.0 msec, temporal resolution=48.2 msec, flip angle=10°, 
receiver bandwidth=201 Hz/pixel, generalized autocalibrating 
partially parallel acquisitions acceleration factor 2 with 24 refer-
ence k-space lines, field of view=300×300 mm, matrix=256 
×174, in-plane resolution=1.2×1.7 mm, slice thickness=6 mm, 
tag thickness=1.5 mm, tag spacing=7 mm, tag orientation= 
±45°. Two different views including both the heart and adjacent 
portions of the liver (three coronal and three sagittal planes) were 
acquired in each subject. The total acquisition time per slice was 
approximately 15–20 sec. 
Image analysis
A Gabor filter bank was used to extract the tag position, after 
which displacement and strains were calculated within the liver 
using custom software developed in MATLAB R2010b (The Math-
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Works Inc., MA, USA).12 Briefly, two families of orthogonally ori-
ented phase images were generated from the filtered grid-tagged 
images, and the associated displacement results were calculated 
from the two sets of phase images. The corresponding principal 
strains, representing tissue deformation, were also calculated 
from the displacement fields.19 The local displacement and corre-
sponding strains were measured in regions of interest (ROI) (ap-
proximately 18 mm × 18 mm or 240 pixels) chosen at liver regions 
just below the diaphragm, where the greatest values occurred. 
The local maximum displacement (MaxDisp), the local maximum 
P1 strain (MaxP1) and the local minimum P2 strain were found 
over the cardiac cycle. The local maximum P1 strain (MaxP1) rep-
resents the amount of greatest elongation or stretch of the tissue 
(always larger than zero), and the local minimum P2 strain (MinP2) 
represents the amount of the greatest compression or shortening 
(always smaller than zero). The analysis was performed in a blind-
ed fashion by a trained expert.
Statistical Analysis
The one-way analysis and variance (ANOVA) test was used to 
compare the means of MaxDisp, MaxP1 and MinP2 among the 
groups of no fibrosis, moderate fibrosis and significant fibrosis 
Figure 1. Representative grid-tagged MRI images with the superimposed color-coded corresponding displacement, P1 strain, and P2 strain maps of 
no fibrosis (A–C), moderate fibrosis (D–F), and significant fibrosis (G–I) patients relative to APRI scores, respectively. APRI, AST to platelet ratio index.
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based on APRI. A p-value of less than 0.05 was considered to in-
dicate statistical significance. However, to account for the multiple 
comparisons performed, a Bonferroni correction was applied so 
that results were defined as significant if P<0.05/3 (P<0.017). 
Data are expressed as mean±standard deviation.
RESULTS
With respect to APRI score, the patients were divided into three 
groups: no fibrosis (≤ 0.5; n=41), moderate fibrosis (0.5-1.5; 
n=23), and significant fibrosis (>1.5; n=21). Figure 1 shows refor-
matted oblique coronal tagged MR images obtained from a repre-
sentative subject from each of these three groups, with the corre-
sponding absolute displacement and P1/P2 strain color-maps 
superimposed over the liver. In the no fibrosis subject, relatively 
high deformation is seen localized below the heart in comparison 
to the moderate and significant fibrosis subjects. This reflects a 
higher resistance to deformation in the significant fibrosis group. 
The mean values of MaxDisp were 2.9±0.9 mm, 2.3±0.7 mm 
and 2.1±0.6 mm in the no fibrosis, moderate fibrosis and signifi-
cant fibrosis groups, respectively, with statistically significant dif-
ferences (P<0.001). After Bonferroni correction, there were statis-
tically significant differences between no fibrosis and moderate 
fibrosis groups (P<0.001) as well as no fibrosis and significant fi-
brosis groups (P=0.001), but there was no statistically significance 
between moderate fibrosis and significant fibrosis groups 
(P=0.556) in regards to maximum displacement.
The mean values of MaxP1 were 0.05±0.02, 0.04±0.02 and 
0.03±0.01 in the no fibrosis, moderate fibrosis and significant fi-
brosis groups, respectively, with statistically significant difference 
(P=0.002). After the Bonferroni correction, there were also statis-
tically significant differences between no fibrosis and moderate fi-
brosis groups (P=0.006) and no fibrosis and significant fibrosis 
groups (P=0.001); however, there was no significant difference 
between moderate fibrosis and significant fibrosis groups 
(P=0.600) in regards to MaxP1. 
The mean values of MinP2 were -0.07±0.02, -0.05±0.02 and 
-0.04±0.01 in the no fibrosis, moderate fibrosis and significant fi-
brosis groups, respectively, with statistically significant difference 
(P<0.001). After the Bonferroni correction, there were also statis-
tically significant differences between no fibrosis and moderate fi-
brosis groups (P=0.001) as well as no fibrosis and significant fi-
brosis groups (P=0.001), but there was no significant difference 
between mo-derate fibrosis and significant fibrosis groups 
(P=0.484) in regards to MinP2 (Table 1). The boxplots of the three 
groups are presented in Figure 2. 
DISCUSSION
The basic principle of tagged MRI is the creation of localized 
perturbation of the magnetization. This can be done selectively, 
similarly to the selective excitation process used for image slice lo-
cation, using spatial modulation of magnetization.20 Tagged MRI 
has been mainly used for the evaluation of regional cardiac func-
tion. Recently, its application in the evaluation of the liver fibrosis 
has been reported, and involves measuring cardiac-induced mo-
tion in the liver12 or respiratory-induced motion in the liver.21  In 
this study, we evaluated the usefulness of tagged MRI in assess-
ing liver fibrosis by measuring cardiac-induced liver motion in 
three patient groups divided by APRI score. This study showed 
that displacement changes occur early during fibrosis and can be 
detected with tagged MRI using cardiac-induced liver motion. The 
Table 1. Summary of the results for all three groups
Mean±SD P-value
MaxDisp (mm) No fibrosis 2.9±0.9 <0.001
Moderate fibrosis 2.3±0.7
Significant fibrosis 2.1±0.6
MaxP1 No fibrosis 0.05±0.2   0.002
Moderate fibrosis 0.04±0.02
Significant fibrosis 0.03±0.01
MinP2 No fibrosis -0.07±0.02 <0.001
Moderate fibrosis -0.05±0.02
Significant fibrosis -0.04±0.01
MaxDisp, local maximum displacement; MaxP1, local maximum P1 strain; MinP2, local minimum P2 strain.
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mean values of maximum displacement, maximum P1 (the 
amount of greatest elongation or stretch of the tissue) and mini-
mum P2 (the amount of greatest compression or shortening of the 
tissue) were significantly different among the patients with no fi-
brosis, moderate fibrosis, and significant fibrosis. After Bonferroni 
correction, there was significant difference in maximum displace-
ment, maximum P1 and minimum P2 between no fibrosis and 
moderate fibrosis, but not between moderate and significant fi-
brosis. Therefore, this method may help in the diagnosis of early 
liver fibrosis rather than advanced fibrosis, which may be useful to 
find the candidate for antiviral treatment.   
Tagged MRI using cardiac-induced liver motion can be imple-
mented on any conventional MRI systems without the need for 
any additional hardware, and involves only a short scan time of 
less than one minute. Therefore, it can be readily and easily incor-
porated in routine liver MRI examinations to obtain additional in-
formation on liver fibrosis. However, this method has some limita-
tions in patients with heart disease or a large amount of ascites or 
pleural disease. Because it uses intrinsic heart motion as the mo-
tion source of the liver, the cardiac motion cannot be well trans-
mitted to the liver in such cases. 
As a limitation of this study, we could not obtain histopatholog-
ic fibrosis grade as the reference standard. Instead of pathologic 
grade, we used the serologic grade of fibrosis, APRI, as the refer-
ence standard. APRI is a simple and objective index with a very 
high degree of accuracy in predicting fibrosis grade.13 Further 
study is needed to correlate with histopathologic fibrosis grade. 
The second limitation is that the methods of measuring local dis-
placement and corresponding strains potentially include measure-
ment errors including reproducibility issues. Therefore a further 
study on reproducibility issues is necessary. The third one is that 
the study population in this study was heterogeneous, including 
the patients with hepatitis B, hepatitis C, and alcoholic liver dis-
ease.
In conclusion, tagged MRI using cardiac-induced liver motion 
can be readily and easily incorporated in routine liver MRI exami-
nations to obtain additional information on liver fibrosis. As a 
complementary tool, tagged MRI using cardiac-induced liver mo-
tion may help in the diagnosis of early liver fibrosis.
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Figure 2. Boxplots of MaxDisp (A, mm), MaxP1 (B), and MinP2 (C) during the cardiac cycle divided by APRI (P<0.001, P=0.002, and P<0.001, respectively). 
APRI, AST to platelet ratio index.
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